SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-008780
Filing Date
2018-07-05
Accepted
2018-07-05 16:10:21
Documents
8
Period of Report
2018-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k070218_oramedpharma.htm 8-K 22344
2 ENGAGEMENT LETTER DATED AS OF JULY 2, 2018 f8k0718ex1-1_oramed.htm EX-1.1 53194
3 FORM OF COMMON STOCK PURCHASE WARRANT f8k0718ex4-1_oramed.htm EX-4.1 90738
4 OPINION OF ZYSMAN, AHARONI, GAYER AND SULLIVAN & WORCESTER LLP f8k0718ex5-1_oramed.htm EX-5.1 9257
5 FORM OF SECURITIES PURCHASE AGREEMENT f8k0718ex10-1_oramed.htm EX-10.1 290637
6 GRAPHIC ex1-1_001.jpg GRAPHIC 6746
7 GRAPHIC eximg_001.jpg GRAPHIC 5005
8 GRAPHIC eximg_002.jpg GRAPHIC 6135
  Complete submission text file 0001213900-18-008780.txt   492542
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 18940682
SIC: 2834 Pharmaceutical Preparations